Kane Biotech (KNE.V) Stock Price
Kane Biotech Price
Revenue has compounded at 16.3% per year over the past 19 years to 427,869.00 CAD. Kane Biotech's net margin stands at -636.0%, down from -286.4% several years earlier.
Kane Biotech stock price
Kane Biotech business model & stock analysis
Frequently asked questions about Kane Biotech
Converted at the current exchange rate, the Kane Biotech share trades at 0.02 EUR (0.03 CAD).
The Kane Biotech share (KNE.V) is listed on 2 stock exchanges, including: Toronto (KNE.V).
The revenue cannot currently be calculated for Kane Biotech.
The profit cannot currently be calculated for Kane Biotech.
The P/E ratio cannot be calculated for Kane Biotech at the moment.
The P/S cannot be calculated for Kane Biotech currently.
The Eulerpool Quality Score for Kane Biotech is 3/10.
The ISIN of Kane Biotech is CA4838092084. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Kane Biotech is KNE.V. The ticker symbol is used to trade Kane Biotech shares on the stock exchange.
Kane Biotech stock
Kane Biotech Peer Group
Kane Biotech Ticker
Kane Biotech FIGI
All fundamentals and in-depth analysis of Kane Biotech
Our stock analysis for Kane Biotech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kane Biotech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.